Samuel J. Ballentine, MD

Samuel J. Ballentine, MD

Assistant Professor, Pathology & Immunology
Residency Program Director

Division

  • Anatomic & Molecular Pathology

Additional Titles

  • Residency Program Director

Education

  • BS, Chemistry: University of Rhode Island, Kingston, RI (2008)
  • MD, New York University School of Medicine, New York, NY (2013)
  • Residency, Anatomic and Clinical Pathology: Icahn School of Medicine at Mount Sinai, New York, NY (2018)
  • Fellowship, Gastrointestinal and Liver Pathology: Icahn School of Medicine at Mount Sinai, New York, NY (2019)

Board Certifications

  • 2018 Diplomate, The American Board of Pathology, Anatomic and Clinical Pathology

Recognition

  • Chief Resident, Department of Pathology, Icahn School of Medicine at Mount Sinai, New York, NY (2016-2017)
  • Rodger C. Haggitt Gastrointestinal Pathology Society Abstract Award (2019)
  • Department of Pathology & Immunology Faculty Teacher of the Year (2020-2021)
  • Department of Pathology & Immunology Special Recognition Award (2022)

Clinical Interests

  • Gastrointestinal & Pancreaticobiliary Pathology
  • Liver Pathology
  • Inflammatory Bowel Disease

Research Interests

I am interested in translational clinicopathologic research related to the field of gastrointestinal, pancreaticobiliary, and liver pathology. I have specific interest and experience in the study of idiopathic inflammatory bowel disease (Crohn’s and Ulcerative colitis) and low grade appendiceal mucinous neoplasms, though I welcome outreach for collaborative projects pertaining to all areas of gastrointestinal medicine.

Selected Publications

PubMed Search
Ballentine S, Lee H, Liu X. Histopathology of Pouch and Para-Pouch Inflammatory and Neoplastic Disorders. Dis Colon Rectum. 2022 Dec 1;65(S1):S57-S68. doi: 10.1097/DCR.0000000000002553. Epub 2022 Jul 21. PubMed PMID: 35895870.
Hawkins WG, Hammill CW, Ballentine SJ. How Biomarkers of Response to Chemotherapy Might Change Patient Management. Ann Surg Oncol. 2022 Nov 23;. doi: 10.1245/s10434-022-12707-6. PubMed PMID: 36422723.
Lee JS, Fleckenstein J, Ballentine SJ. Cystic Angiomatosis of the Bone, Liver, and Spleen. Int J Surg Pathol. 2022 Aug 9;:10668969221118326. doi: 10.1177/10668969221118326. PubMed PMID: 35946095.
Higgins CB, Mayer AL, Zhang Y, Franczyk M, Ballentine S, Yoshino J, DeBosch BJ. SIRT1 selectively exerts the metabolic protective effects of hepatocyte nicotinamide phosphoribosyltransferase. Nat Commun. 2022 Feb 28;13(1):1074. doi: 10.1038/s41467-022-28717-7. PubMed PMID: 35228549; PubMed Central PMCID: PMC8885655.
Xie Y, Newberry EP, Brunt EM, Ballentine SJ, Soleymanjahi S, Molitor EA, Davidson NO. Inhibition of chylomicron assembly leads to dissociation of hepatic steatosis from inflammation and fibrosis. J Lipid Res. 2021;62:100123. doi: 10.1016/j.jlr.2021.100123. Epub 2021 Sep 24. PubMed PMID: 34563519; PubMed Central PMCID: PMC8515302.
Pothuri V, Herndon J, Ballentine SJ, Lim KH, Fields RC. A Case of a Pathological Complete Response to Neoadjuvant Nivolumab plus Ipilimumab in Periampullary Adenocarcinoma. Oncologist. 2021 Sep;26(9):722-726. doi: 10.1002/onco.13821. Epub 2021 May 26. PubMed PMID: 33982365; PubMed Central PMCID: PMC8417855.
Kmeid M, Liu X, Ballentine S, Lee H. Idiopathic Non-Cirrhotic Portal Hypertension and Porto-Sinusoidal Vascular Disease: Review of Current Data. Gastroenterology Res. 2021 Apr;14(2):49-65. doi: 10.14740/gr1376. Epub 2021 Apr 21. Review. PubMed PMID: 34007347; PubMed Central PMCID: PMC8110235.
Ballentine SJ, Carr J, Bekhor EY, Sarpel U, Polydorides AD. Updated staging and patient outcomes in low-grade appendiceal mucinous neoplasms. Mod Pathol. 2021 Jan;34(1):104-115. doi: 10.1038/s41379-020-0628-7. Epub 2020 Jul 29. PubMed PMID: 32728224.
Harpaz N, Ballentine S, Colombel JF, E Sands B, Ko HM. Microscopic heterogeneity in ulcerative colitis: implications for microscopic measurement of disease activity. Gut. 2020 Feb;69(2):401-402. doi: 10.1136/gutjnl-2018-318137. Epub 2019 Feb 5. PubMed PMID: 30723105.
Solomon D, Bekhor E, Leigh N, Maniar YM, Totin L, Hofstedt M, Aycart SN, Carr J, Ballentine S, Magge DR, Golas BJ, Pai RK, Polydorides AD, Bartlett DL, Labow DM, Choudry HA, Sarpel U. Surveillance of Low-Grade Appendiceal Mucinous Neoplasms With Peritoneal Metastases After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: Are 5 Years Enough? A Multisite Experience. Ann Surg Oncol. 2020 Jan;27(1):147-153. doi: 10.1245/s10434-019-07678-0. Epub 2019 Aug 5. PubMed PMID: 31385130.

Assistant
Lisa Schreiber
314-273-4843
lisa.schreiber@wustl.edu
BJCIH Room 3422